Elan

The suspense inside the offices of Eli Lilly this autumn was all but unbearable. After working on a drug to fight Alzheimer’s disease for 15 years, em(...)

Consumer health and generics group Perrigo is reviewing strategic options for royalty rights from sales of its multiple sclerosis drug Tysabri after r(...)

Are you a saver or a spender? I enjoy both equally, but fortunately over the years I’ve managed to be a better saver than a spender – just about! Do(...)

Malin, the Irish-based company set up by a number of former Elan executives to invest in privately held life science assets, is to take a 31 per cent (...)

Top executives of Dublin-based over-the-counter drug company Perrigo arrived in Israel today for meetings with investors as they seek to fend off a ho(...)

Listed life sciences investment group Malin has reported its maiden set of results. Excluding the costs of establishing the company, Malin reported a (...)

Irish over-the-counter drug company Perrigo has filed a lawsuit against suitor Mylan in a Manhattan court. The legal action comes as Perrigo urged its(...)

Shareholders in over-the-counter drug specialists Perrigo receive their latest quarterly dividend today. It comes as they mull the formal offer for th(...)

Irish life sciences investment firm Malin completed its initial series of asset purchases with two more investments on Monday and said director and fo(...)

Revenue at Irish drug group Alkermes jumped almost 24 per cent in the first three months of the year, to $161.2 million, ahead of analyst expectations(...)